SCHEMBL14907655

SCHEMBL14907655

Nc1cccc(CCC(=O)NCc2ccnc3[nH]ccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.43
BTK Q06187 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PRKCI P41743 1/20 0.40
ALDH1A1 P00352 1/20 0.39
PTPN1 P18031 1/20 0.38
ROCK1 Q13464 1/20 0.38
HPGDS O60760 1/20 0.38
FLT3 P36888 1/20 0.38
HCAR2 Q8TDS4 1/20 0.37
CIT O14578 1/20 0.37
NUDT1 P36639 1/20 0.37
CDK8 P49336 2/20 0.37
THRA P10827 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907646 0.86 ROCK2 (0.43) RETBTKPRKCIROCK1CIT
SCHEMBL14907647 0.81 ALDH1A1 (0.42) RETHPGDPRKCIALDH1A1NUDT1
SCHEMBL14907701 0.81 RET (0.39) RETBTKPRKCIROCK1CIT
SCHEMBL14907659 0.79 AURKA (0.42) RETBTKCYP3A4CYP2C19PTPN1
SCHEMBL14894298 0.78 VCP (0.48) RETBTKCYP1A2CYP3A4CYP2C9
SCHEMBL14907679 0.77 CYP3A4 (0.44) RETCYP3A4PRKCIROCK1CIT
SCHEMBL16141574 0.77 IKBKB (0.39) RETPRKCIROCK1CIT
SCHEMBL14907738 0.77 PRKCI (0.37) RETBTKPRKCIROCK1CIT
SCHEMBL14907674 0.76 PRKCI (0.36) RETBTKPRKCIROCK1FLT3
SCHEMBL7835550 0.74 GAA (0.58) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B RET 2315/4885BTK 418/4885CYP1A2 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.